Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$613.69 USD
-6.56 (-1.06%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $613.82 +0.13 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
TMO 613.69 -6.56(-1.06%)
Will TMO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TMO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TMO
TMO Stock to Gain From Expanded Bioanalytical Services in Sweden
The Zacks Analyst Blog Highlights JPMorgan Chase, Thermo Fisher, Arista Networks, United Homes Group and GSI
TMO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Top Research Reports for JPMorgan, Thermo Fisher & Arista Networks
Why Is Thermo Fisher (TMO) Up 1.6% Since Last Earnings Report?
Reasons to Retain Thermo Fisher (TMO) in Your Portfolio Now
Other News for TMO
Olink Proteomics Announces the 'Olink Proteomics World' Virtual Conference: A Novel Platform Exploring the Latest Advancements in Proteomics and Proteogenomics
Thermo Fisher price target raised by $20 at JPMorgan, here's why
Thermo Fisher price target raised by $25 at Morgan Stanley, here's why
Thermo Fisher price target raised by $65 at Stifel, here's why
November 15th Options Now Available For Thermo Fisher Scientific (TMO)